Amy Elazzouzi - Feb 18, 2025 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Senior Vice President, Finance
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Stock symbol
AURA
Transactions as of
Feb 18, 2025
Transactions value $
-$10,881
Form type
4
Date filed
2/18/2025, 07:31 PM
Previous filing
Feb 4, 2025
Next filing
Apr 16, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Sale -$10.9K -1.4K -1.68% $7.75 82.3K Feb 18, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.